Approvals/TGA/FOSAPREPITANT MSN fosaprepitant (as dimeglumine) 150 mg powder for injection vial

Approved

STANDARD

FOSAPREPITANT MSN fosaprepitant (as dimeglumine) 150 mg powder for injection vial

Reach Pharmaceuticals Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: fcd7f2c7b0b86519
Product Name: FOSAPREPITANT MSN fosaprepitant (as dimeglumine) 150 mg powder for injection vial
Artg Id: 372680
Artg Name: FOSAPREPITANT MSN fosaprepitant (as dimeglumine) 150 mg powder for injection vial
Sponsor: Reach Pharmaceuticals Pty Ltd
Company Detail Path: /organization/reach-pharmaceuticals-pty-ltd
Artg Date: 2022-10-19
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/a76075b20b55606c2db6efe7852c7773.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/e50e7bce16537fc9fa632210f4405964.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

fcd7f2c7b0b86519

Type

Standard